Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mycmed.2021.101168 http://scihub22266oqcxt.onion/10.1016/j.mycmed.2021.101168 34186378!8206624!34186378     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Mycol+Med 2021 ; 31 (3): 101168 Nephropedia Template TP {{tp|p=34186378|t=2021. COVID-19 and Candida duobushaemulonii superinfection: A case report |pdf=|usr=}}{{34186378}} gab.com Text COVID-19 and Candida duobushaemulonii superinfection: A case report JO: J Mycol Med http://www.kidney.de/pget.php?&tw=1&pmid=34186378 #FOAvip INTRODUCTION: Critically ill COVID-19 patients are at high risk for nosocomial bacterial and fungal infections due to several predisposing factors such as intensive care unit stay, mechanical ventilation, and broad-spectrum antibiotics. Data regarding multidrug resistant (MDR) Candida species in COVID-19 patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections. CASE DESCRIPTION: A 34-year-old male presented to our institution with acute respiratory distress syndrome (ARDS) due to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics and prolonged mechanical ventilation. He died after recurrent pneumothorax led to respiratory failure and cardiac arrest. DISCUSSION: Bacterial and fungal infections are common complications of viral pneumonia in critically ill patients. Data regarding these infections in COVID-19 patients has been poorly studied with only a few cases reporting secondary infection, mostly without identifying specific pathogens. Prolonged hospital stays, invasive interventions (central venous catheter, mechanical ventilation), and the use of broad-spectrum antibiotics in COVID-19 infections could carry a high risk of bacterial and/or fungal superinfections. CONCLUSION: Strategies to improve outcome in COVID-19 ICU patients should include early recognition of candidemia and appropriate antifungal therapy. Twit Text FOAVip COVID-19 and Candida duobushaemulonii superinfection: A case report ????J Mycol Med http://www.kidney.de/pget.php?&tw=1&pmid=34186378 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34186378 #FOAvip English Wikipedia <ref>{{Cite pmid|34186378}}</ref> COVID-19 and Candida duobushaemulonii superinfection: A case report #MMPMID34186378 Awada B; Alam W; Chalfoun M; Araj G; Bizri AR J Mycol Med 2021[Sep]; 31 (3): 101168 PMID34186378show ga INTRODUCTION: Critically ill COVID-19 patients are at high risk for nosocomial bacterial and fungal infections due to several predisposing factors such as intensive care unit stay, mechanical ventilation, and broad-spectrum antibiotics. Data regarding multidrug resistant (MDR) Candida species in COVID-19 patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections. CASE DESCRIPTION: A 34-year-old male presented to our institution with acute respiratory distress syndrome (ARDS) due to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics and prolonged mechanical ventilation. He died after recurrent pneumothorax led to respiratory failure and cardiac arrest. DISCUSSION: Bacterial and fungal infections are common complications of viral pneumonia in critically ill patients. Data regarding these infections in COVID-19 patients has been poorly studied with only a few cases reporting secondary infection, mostly without identifying specific pathogens. Prolonged hospital stays, invasive interventions (central venous catheter, mechanical ventilation), and the use of broad-spectrum antibiotics in COVID-19 infections could carry a high risk of bacterial and/or fungal superinfections. CONCLUSION: Strategies to improve outcome in COVID-19 ICU patients should include early recognition of candidemia and appropriate antifungal therapy. |Adult[MESH] |Antifungal Agents/therapeutic use[MESH] |COVID-19/*complications[MESH] |Candida[MESH] |Candidemia/complications/*drug therapy[MESH] |Fatal Outcome[MESH] |Humans[MESH] |Male[MESH] |Respiration, Artificial[MESH] |Respiratory Distress Syndrome[MESH] |Saccharomycetales[MESH]COVID-19 and Candida duobushaemulonii superinfection: A case report (epmc).pdf DeepDyve Pubget Overpricing